Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer

The present study evaluated the prognostic value of the epidermal growth factor receptor (EGFR) mutation status, and excision repair cross-complementation group 1 (ERCC1) and thymidylate synthase (TS) expression following intercalated tyrosine kinase inhibitor (TKI) therapy and platinum- and pemetre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chang-Sheng, Liu, Tu-Chen, Lai, Ji-Ching, Yang, Shun-Fa, Tsao, Thomas Chang-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707758/
https://www.ncbi.nlm.nih.gov/pubmed/29200955
http://dx.doi.org/10.7150/ijms.21938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707758/
https://www.ncbi.nlm.nih.gov/pubmed/29200955
http://dx.doi.org/10.7150/ijms.21938

Ejemplares similares